[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:oropharyngeal-carcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":256,"states":265},"Oropharyngeal Carcinoma",40,37,[8,16,22,28,35,41,47,53,59,65,71,77,83,89,95,101,108,115,121,127,133,139,145,151,158,164,170,176,182,188,194,200,206,212,218,224,230,236,243,250],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07178301","Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial",[12],"Phase 2","RECRUITING","2026-08-26T02:15:58.452248Z","2026-07-19T19:36:05.065224Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06984861","A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer",[12],"2026-08-26T02:16:27.227548Z","2026-05-05T02:43:29.643338Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06554158","De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers",[],"2026-08-26T02:16:05.813655Z","2026-05-05T02:43:29.477332Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT05451004","SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer",[32],"Phase 3","2026-08-26T02:15:43.339060Z","2026-05-05T02:43:29.473069Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06702033","The Minimalist Trial-2",[12],"2026-08-26T02:16:52.995882Z","2026-05-05T02:43:29.138139Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT03215719","Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma",[12],"2026-08-26T02:17:34.833510Z","2026-05-05T02:43:29.074089Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT05894083","A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)",[12],"2026-08-26T02:17:43.321968Z","2026-05-05T02:43:28.218746Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT05799144","pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w\u002FAdvanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer",[12],"2026-08-26T02:16:10.529598Z","2026-05-05T02:43:28.217841Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT05388773","Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer",[12],"2026-08-26T02:17:53.433613Z","2026-05-05T02:43:27.421473Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT06902623","Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy",[],"2026-08-26T02:19:20.945539Z","2026-05-05T02:43:27.405933Z",{"nct_id":72,"title":73,"phases":74,"status":13,"updated_at":75,"content_modified":76},"NCT06309225","Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly",[],"2026-08-26T02:15:20.225313Z","2026-05-05T02:43:27.403976Z",{"nct_id":78,"title":79,"phases":80,"status":13,"updated_at":81,"content_modified":82},"NCT05491512","A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer",[12],"2026-08-26T02:16:09.452956Z","2026-05-05T02:43:27.316218Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":87,"content_modified":88},"NCT05800574","Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer",[12],"2026-08-26T02:16:50.548894Z","2026-05-05T02:43:27.274627Z",{"nct_id":90,"title":91,"phases":92,"status":13,"updated_at":93,"content_modified":94},"NCT07290621","Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer",[12],"2026-08-26T02:16:36.513735Z","2026-05-05T02:43:26.936724Z",{"nct_id":96,"title":97,"phases":98,"status":13,"updated_at":99,"content_modified":100},"NCT06445114","Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer",[12],"2026-08-26T02:17:27.435233Z","2026-04-29T02:57:57.120187Z",{"nct_id":102,"title":103,"phases":104,"status":13,"updated_at":106,"content_modified":107},"NCT06319963","A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer",[105],"Phase 1\u002FPhase 2","2026-08-26T02:18:00.873391Z","2026-05-05T02:43:28.173901Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":113,"content_modified":114},"NCT05172245","Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer",[112],"Phase 1","2026-08-26T02:17:41.695983Z","2026-07-19T19:36:05.120891Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT05686226","E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers",[12],"2026-08-26T02:15:28.524219Z","2026-07-05T05:32:16.812867Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT05639972","E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers",[105],"2026-08-26T02:17:33.002248Z","2026-07-05T05:32:16.809101Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT06997068","Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent\u002FMetastatic Head and Neck Cancer in a Rural Midwest United States Population",[12],"2026-08-26T02:15:41.377360Z","2026-07-05T05:32:16.725924Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":137,"content_modified":138},"NCT07195734","Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer",[12],"2026-08-26T02:18:11.042248Z","2026-07-05T05:32:16.659005Z",{"nct_id":140,"title":141,"phases":142,"status":13,"updated_at":143,"content_modified":144},"NCT07156227","Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma",[112],"2026-08-26T02:17:44.240289Z","2026-06-04T01:30:07.902043Z",{"nct_id":146,"title":147,"phases":148,"status":13,"updated_at":149,"content_modified":150},"NCT05307939","A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)",[12],"2026-08-26T02:19:22.562392Z","2026-05-05T02:43:28.812774Z",{"nct_id":152,"title":153,"phases":154,"status":13,"updated_at":156,"content_modified":157},"NCT04265430","Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors",[155],"Phase 4","2026-08-26T02:15:52.238965Z","2026-04-29T02:57:57.104187Z",{"nct_id":159,"title":160,"phases":161,"status":13,"updated_at":162,"content_modified":163},"NCT06305676","Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)",[],"2026-08-26T02:18:56.409949Z","2026-05-13T02:55:06.434457Z",{"nct_id":165,"title":166,"phases":167,"status":13,"updated_at":168,"content_modified":169},"NCT05880797","Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma",[],"2026-08-26T02:19:04.543908Z","2026-05-13T02:55:06.390798Z",{"nct_id":171,"title":172,"phases":173,"status":13,"updated_at":174,"content_modified":175},"NCT06381505","RetracTOR\u002F Retractor for Image Guided Trans-Oral Surgery",[],"2026-08-26T02:17:47.813245Z","2026-05-13T02:55:06.485262Z",{"nct_id":177,"title":178,"phases":179,"status":13,"updated_at":180,"content_modified":181},"NCT05207098","A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy",[],"2026-08-26T02:17:30.961790Z","2026-06-06T00:48:49.527149Z",{"nct_id":183,"title":184,"phases":185,"status":13,"updated_at":186,"content_modified":187},"NCT05337631","Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy",[],"2026-08-26T02:19:19.162260Z","2026-05-13T02:55:06.302047Z",{"nct_id":189,"title":190,"phases":191,"status":13,"updated_at":192,"content_modified":193},"NCT03010150","Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer",[],"2026-08-26T02:16:32.589113Z","2026-05-13T02:55:06.106681Z",{"nct_id":195,"title":196,"phases":197,"status":13,"updated_at":198,"content_modified":199},"NCT02012699","Integrated Cancer Repository for Cancer Research",[],"2026-08-26T02:16:35.654046Z","2026-05-13T02:55:06.082833Z",{"nct_id":201,"title":202,"phases":203,"status":13,"updated_at":204,"content_modified":205},"NCT00900419","Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers",[],"2026-08-26T02:18:49.989941Z","2026-05-13T02:55:06.067169Z",{"nct_id":207,"title":208,"phases":209,"status":13,"updated_at":210,"content_modified":211},"NCT07278557","Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia",[12],"2026-08-26T02:19:11.399072Z","2026-05-05T02:43:28.709829Z",{"nct_id":213,"title":214,"phases":215,"status":13,"updated_at":216,"content_modified":217},"NCT04151082","High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors",[105],"2026-08-26T02:18:47.742071Z","2026-07-05T03:45:20.246977Z",{"nct_id":219,"title":220,"phases":221,"status":13,"updated_at":222,"content_modified":223},"NCT06682494","Enhancing Oral Cancer Awareness",[],"2026-08-26T02:18:32.765187Z","2026-05-05T02:43:27.595272Z",{"nct_id":225,"title":226,"phases":227,"status":13,"updated_at":228,"content_modified":229},"NCT05793151","Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy",[],"2026-08-26T02:16:12.203827Z","2026-05-05T02:43:29.326308Z",{"nct_id":231,"title":232,"phases":233,"status":13,"updated_at":234,"content_modified":235},"NCT03916809","EMST in Patients Undergoing CRT for HNCA",[],"2026-08-26T02:17:22.949982Z","2026-05-05T02:35:31.700615Z",{"nct_id":237,"title":238,"phases":239,"status":240,"updated_at":241,"content_modified":242},"NCT04444869","Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer",[12],"UNKNOWN","2026-08-03T01:56:19.375288Z","2026-05-05T02:43:27.629541Z",{"nct_id":244,"title":245,"phases":246,"status":247,"updated_at":248,"content_modified":249},"NCT04667585","Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx",[],"ACTIVE_NOT_RECRUITING","2026-08-03T02:35:59.254098Z","2026-05-05T02:43:27.433162Z",{"nct_id":251,"title":252,"phases":253,"status":247,"updated_at":254,"content_modified":255},"NCT05787639","Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)",[12],"2026-08-03T03:02:32.170340Z","2026-05-05T02:43:26.748629Z",[257,261],{"biomarker":258,"count":259,"slug":260},"HPV",20,"hpv",{"biomarker":262,"count":263,"slug":264},"CDKN2A wt Allele",16,"cdkn2a-wt-allele",[266,270,274,278,281,285,288,292,295,298,301,304,308,311,314],{"state":267,"count":268,"slug":269},"New York",9,"new-york",{"state":271,"count":272,"slug":273},"New Jersey",8,"new-jersey",{"state":275,"count":276,"slug":277},"Florida",7,"florida",{"state":279,"count":276,"slug":280},"North Carolina","north-carolina",{"state":282,"count":283,"slug":284},"Illinois",6,"illinois",{"state":286,"count":283,"slug":287},"Missouri","missouri",{"state":289,"count":290,"slug":291},"California",5,"california",{"state":293,"count":290,"slug":294},"Maryland","maryland",{"state":296,"count":290,"slug":297},"Ohio","ohio",{"state":299,"count":290,"slug":300},"Pennsylvania","pennsylvania",{"state":302,"count":290,"slug":303},"Texas","texas",{"state":305,"count":306,"slug":307},"Kansas",3,"kansas",{"state":309,"count":306,"slug":310},"Michigan","michigan",{"state":312,"count":306,"slug":313},"Oregon","oregon",{"state":315,"count":306,"slug":316},"Wisconsin","wisconsin"]